AstraZeneca-Daiichi Sankyo Enhertu gets USFDA accelerated nod for metastatic HER2-positive solid tumours Ruchika Sharma7 April 2024 11:30 AM ISTCambridge: AstraZeneca and Daiichi Sankyo's Enhertu (trastuzumab deruxtecan) has been approved in the US for the treatment of adult patients...
USFDA approves Carvykti for patients with Relapsed or Refractory Multiple Myeloma who have received at least one prior line of therapy Ruchika Sharma7 April 2024 10:00 AM ISTHorsham: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved CARVYKTI (ciltacabtagene...
Long-term progesterone use increase intracranial meningioma risk in women: BMJ Jacinthlyn Sylvia6 April 2024 8:00 AM ISTA comprehensive national case-control study conducted in France revealed a significant link between the use of specific progestogen-based medications...
Blood test can predict risk of relapse in advanced bladder cancer patients following surgery, suggests study Dr. Kamal Kant Kohli6 April 2024 7:00 AM ISTTesting for tumour DNA in the blood can successfully identify advanced bladder cancer patients who will not relapse following surgery, new research...
Relugolix Rapidly Achieves Sustained Castration in Prostate Cancer Patients Undergoing Radiotherapy: Study Dr Riya Dave3 April 2024 10:30 PM ISTProstate cancer remains one of the most prevalent cancers in men worldwide, often requiring a multimodal treatment approach for optimal management....
Incidence of cancer significantly higher in tuberculosis patients, finds study Dr. Kamal Kant Kohli3 April 2024 8:45 PM ISTSouth Korea: A recent study has shown an association between tuberculosis (TB) and cancer, with those with current or previous TB more likely to have...
AstraZeneca, Daiichi Sankyo Datopotamab deruxtecan application accepted in US for pretreated metastatic HR-positive, HER2-negative breast cancer Ruchika Sharma3 April 2024 12:30 PM ISTAstraZeneca and Daiichi Sankyo's Biologics License Application (BLA) for datopotamab deruxtecan (Dato-DXd) has been accepted in the US for the...
Polybrominated Diphenyl Ethers Exposure may Increase Cancer Mortality Risk: JAMA Jacinthlyn Sylvia3 April 2024 3:00 AM ISTPolybrominated Diphenyl Ethers (PBDEs) is widely recognized for their endocrine-disrupting properties and have been a growing concern due to their...
AI-based app can help physicians find skin melanoma: Study Dr. Kamal Kant Kohli2 April 2024 7:30 PM ISTA mobile app that uses artificial intelligence, AI, to analyse images of suspected skin lesions can diagnose melanoma with very high precision. This...
Alembic Pharma gets tentative USFDA nod for breast cancer drug Ribociclib in March Quarter Ruchika Sharma2 April 2024 3:17 PM ISTVadodara: Alembic Pharma has informed in a BSE filing that the Company has received tentative approval for Ribociclib Tablets, 200 mg,...
European Commission approves Merck Keytruda plus Chemotherapy for lung cancer Ruchika Sharma1 April 2024 5:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the European Commission (EC) has approved KEYTRUDA,...
Combining prostate MRI with a blood test may help avoid unnecessary prostate biopsies, highlights JAMA research Dr. Kamal Kant Kohli31 March 2024 7:45 PM ISTResearchers New Brigham have found in a new study that MRI of the prostate, combined with a blood test, can help determine if a prostate lesion...
